Medications for Diffuse Large Bcell Lymphoma

1 result

Zynlonta (loncastuximab tesirine)

(loncastuximab tesirine)
ADC Therapeutics America, Inc.
Usage: ZYNLONTA is indicated for adult patients with relapsed or refractory large B-cell lymphoma, including various forms such as diffuse large B-cell lymphoma, after two or more lines of systemic therapy. Approval is under accelerated conditions based on overall response rate, pending further clinical benefit verification.